Skip to content

Corcept Therapeutics

US · CORT #1285 by market cap Listed 1970
63.62 -1.36 -2.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Corcept Therapeutics

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Founded
1998
CEO
Dr. Joseph K. Belanoff, M.D.
Employees
730
Headquarters
Redwood City, California, United States of America
Fiscal year end
12-31
Website
corcept.com

Company profile

Exchange
US
Symbol
CORT
Market-cap rank
#1285
Listing date
1970-01-01
Market cap
6.96B
Float cap
6.22B
Shares out
109.44M
Float shares
97.83M

Sectors & themes

Biotechnology Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Corcept Therapeutics discussion 0 comments

Add a comment